ArticleActa neurochirurgica2025
Cerebral microdialysis values in healthy brain tissue - a scoping review.
Article in Acta neurochirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Coagulopathy in Critically Ill Patients With Sepsis: Protocol for a Scoping Review.Acta anaesthesiologica Scandinavica · 2026Article
- A novel strategy for the photothermal treatment and electroencephalogram monitoring ofRSC advances · 2026Article
- The brain's sweet spot: why microglia can run on fructose metabolism.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntracerebral microdialysis is an advanced method to guide clinicians during intensive care of patients with severe acute brain injury. Using intracerebral microdialysis, markers of brain metabolism and homeostasis can be analysed. Currently, trends are considered more important in clinical decision-making than absolute values. Establishing absolute reference values in healthy brain tissue may facilitate an earlier detection of abnormal brain tissue metabolism and provide better decision support for clinicians. However, the current evidence on normal values in the uninjured human brain has not previously been summarized. The aim of this study was to summarise the literature regarding microdialysate concentrations of common markers of brain energy metabolism (glucose, lactate, pyruvate, glutamate, and glycerol) in vivo in healthy brain tissue of humans and gyrencephalic animals.
methodMEDLINE, Embase, CENTRAL, CINAHL, and Web of Science were searched for published studies that report values of microdialysis in healthy brain tissue. In order to identify unpublished studies, we searched ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (ICTRP), and EU Clinical Trials Register. Study quality was evaluated using a pre-specified protocol.
resultOut of 3257 studies identified, 39 studies were included. Six of these studies were in humans (total n = 54), 26 in pigs/swine (n = 432), two on monkeys (n = 10), one in sheep (n = 15), and one in dogs (n = 10). We found a high degree of clinical and methodological heterogeneity in both human and gyrencephalic animal studies.
conclusionThis scoping review identified studies that applied microdialysis to measure common biomarkers in healthy brain tissue. The clinical and methodological heterogeneity between the measured values was substantial, limiting any conclusions. Furthermore, the quality of several human studies was moderate at best. Methodologically comparable studies are warranted to establish reference values for markers of brain energy metabolism using intracerebral microdialysate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.